References
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. https://doi.org/10.3322/caac.20107
- Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993;90:1937-1941. https://doi.org/10.1073/pnas.90.5.1937
- Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 1991;64:327-336. https://doi.org/10.1016/0092-8674(91)90642-C
- Van Roy F, Mareel M. Tumour invasion: Effects of cell adhesion and motility. Trends Cell Biol. 1992;2:163-169. https://doi.org/10.1016/0962-8924(92)90035-L
- Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183:10-17. https://doi.org/10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I
- Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450-1459. https://doi.org/10.1016/0006-291X(84)91253-1
- Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990;111:2097-2108. https://doi.org/10.1083/jcb.111.5.2097
- Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Van-de Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802-804. https://doi.org/10.1126/science.1846706
- Kim CH, Koh YW, Han JH, Kim JW, Lee JS, Baek SJ, et al. c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head Neck. 2010;32:1655-1664. https://doi.org/10.1002/hed.21383
- Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, et al. Ex-pression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol. 2006;126:88-94. https://doi.org/10.1080/00016480510037014
- Kim CH, Lee JS, Kang SO, Bae JH, Hong SP, Kahng H. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol. 2007;43:1021-1025. https://doi.org/10.1016/j.oraloncology.2006.11.016
- Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133:3262S-3267S. https://doi.org/10.1093/jn/133.10.3262S
- Crespy V, Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004;134:3431S-3440S. https://doi.org/10.1093/jn/134.12.3431S
- Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89:254-261. https://doi.org/10.1111/j.1349-7006.1998.tb00556.x
- Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004;64:8715-8722. https://doi.org/10.1158/0008-5472.CAN-04-2840
- Liang YC, Lin-shiau SY, Chen CF, Lin JK. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 1997;67:55-65. https://doi.org/10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V
- Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cytokine. Lancet. 1995;345:293-295. https://doi.org/10.1016/S0140-6736(95)90279-1
- Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991;67:901-908. https://doi.org/10.1016/0092-8674(91)90363-4
- Wang Y, Selden AC, Morgan N, Stamp GW, Hodgson HJ. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol. 1994;144:675-682.
- Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182:802-809. https://doi.org/10.1016/0006-291X(92)91803-X
- Uchida D, Kawamata H, Omotehara F, Nakashiro K, Kimura-Yanagawa T, Hino S, et al. Role of HGF/c-met system in invasion and me-tastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer. 2001;93:489-496. https://doi.org/10.1002/ijc.1368
- Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer. 1998;82:1513-1520. https://doi.org/10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7
- Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem. 1995;270:27780-27787. https://doi.org/10.1074/jbc.270.46.27780
- Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem. 2004;279:12755-12762. https://doi.org/10.1074/jbc.M312333200